Abstract 23 Table 1

Demographics and the number of follow-up HCM patients who developed new symptoms or required medication changes and their respective ESC-SCD risk categories

A total of 47 follow-up HCM patients were identified over a 6-month period in 2018
Age61.4 ± 12.2
Male Gender26
ESC-SCD Risk StratificationNDeveloped New SymptomsRequired Medication ChangesCardiac admissions in 2-years
Low388 (21%)11 (29%)2 (5%)
Moderate41 (25%)2 (50%)0 (0%)
High41 (25%)2 (50%)0 (0%)